BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/24/2018 1:07:06 AM | Browse: 1090 | Download: 2031
 |
Received |
|
2018-09-18 00:54 |
|
Peer-Review Started |
|
2018-09-18 06:21 |
|
First Decision by Editorial Office Director |
|
2018-10-11 16:37 |
|
Return for Revision |
|
2018-10-12 00:49 |
|
Revised |
|
2018-11-20 06:52 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2018-11-23 08:11 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2018-11-24 04:38 |
|
Articles in Press |
|
2018-11-24 04:38 |
|
Edit the Manuscript by Language Editor |
|
2018-11-30 14:14 |
|
Typeset the Manuscript |
|
2018-12-17 00:31 |
|
Publish the Manuscript Online |
|
2018-12-24 01:07 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Research & Experimental Medicine |
| Manuscript Type |
Case Report |
| Article Title |
Posaconazole-associated severe hyperbilirubinemia in acute myeloid leukemia following chemotherapy: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zai-Wei Song, Yu-Chen Pan, Zhen-Cheng Huang, Wen-Xi Liu, Rong-Sheng Zhao, Hong-Mei Jing and Fei Dong |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Fei Dong, MD, Doctor, Doctor, Department of Hematology, Peking University Third Hospital, 49 North Garden Rd., Haidian District, Beijing 100191, China. knowflying@163.com |
| Key Words |
Posaconazole; Hyperbilirubinemia; Liver injury; Acute myeloid leukemia; Case report |
| Core Tip |
Posaconazole is safe and tolerable in most cases and posaconazole-associated severe hyperb-ilirubinemia is usually very rare. For patients with hematological malignancy who develop severe infection following chemotherapy, combination of anti-infective drugs may contribute to higher risk of posaconazole-induced severe liver injury of cholestatic type. There¬fore, for patients with hematological malignancy, liver and renal function should be monitored closely before and during the administration of posaconazole. |
| Publish Date |
2018-12-24 01:07 |
| Citation |
Song ZW, Pan YC, Huang ZC, Liu WX, Zhao RS, Jing HM, Dong F. Posaconazole-associated severe hyperbilirubinemia in acute myeloid leukemia following chemotherapy: A case report. World J Clin Cases 2018; 6(16): 1206-1209 |
| URL |
https://www.wjgnet.com/2307-8960/full/v6/i16/1206.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v6.i16.1206 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
